Related Experiment Video

Updated: Jan 30, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.7K

Chronic kidney disease predicts atrial fibrillation in patients with ST-segment elevation myocardial infarction

Răzvan Constantin Șerban1,2, Ioana Șuș1,2, Eva Katalin Lakatos1,2

  • 1University of Medicine and Pharmacy of Tîrgu Mureș, Tîrgu Mureș, Romania.

Acta Cardiologica
|January 17, 2019
PubMed

Insights

Chronic kidney disease (CKD) independently predicts atrial fibrillation (AF) in ST-segment elevation myocardial infarction (STEMI) patients. Identifying CKD aids in managing AF risk and guiding prophylactic strategies for these high-risk individuals.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Atrial fibrillation (AF) is a common complication of ST-segment elevation myocardial infarction (STEMI).
  • Predictors of AF in STEMI include acute phase factors and pre-existing conditions.
  • Novel AF predictors identified in the general population warrant evaluation in the STEMI context.

Purpose of the Study:

  • To assess the predictive ability of novel factors for STEMI-related AF.
  • To evaluate the association between chronic kidney disease (CKD) and STEMI-related AF.
  • To identify patients at higher risk for AF following STEMI.

Main Methods:

  • Retrospective analysis of STEMI patients treated with primary percutaneous coronary intervention (PCI).
  • Evaluation of classic and novel AF predictors, including body mass index (BMI), diabetes, CKD, and chronic obstructive pulmonary disease (COPD).
  • Statistical analysis, including multiple regression, to determine independent predictors of STEMI-related AF.

Main Results:

  • 10.5% of 629 STEMI patients developed AF.
  • AF patients exhibited higher Killip class, lower post-PCI TIMI flow, were older, and had higher rates of heart failure and prior myocardial infarction.
  • Chronic kidney disease (CKD) was significantly more prevalent in AF patients and remained a strong independent predictor of STEMI-related AF.

Conclusions:

  • Chronic kidney disease (CKD) is a significant independent risk factor for developing AF in STEMI patients.
  • CKD can identify STEMI patients at increased risk for AF.
  • These findings support closer follow-up and intensified prophylactic strategies for STEMI patients with CKD.

Keywords:
Atrial fibrillationST-segment elevation myocardial infarctionchronic kidney diseasepredictionprimary percutaneous coronary intervention

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.8K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.1K

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
728
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
646
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
467
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
388
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K